News

Breakyl (also known as Onsolis or BEMA Fentanyl) is indicated for the management of pain in opioid tolerant adult patients with cancer. Meda claims that Breakyl uses a

Abbott has posted net earnings of $891m for the third quarter 2010, or $0.57 per diluted share, compared to net earnings of $1.48bn, or $0.95 per diluted share,

Alcon has posted a net earnings of $446m for the third quarter 2010, or $1.47 per diluted share, compared to net earnings of $515m, or $1.71 per diluted

Previously, Parsons was the chief financial officer for both private and public life science companies including Amorfix Life Sciences, Trillium Therapeutics and Lorus Therapeutics. DiaMedica president and CEO

Under the partnership, HCPlexus and Healthline Networks are expected to extend their current advertising networks, as well as the new point-of-care information platform, to provide contextual and direct

The group will draw on expertise developed by the company in its ten years of building custom biomedical data management applications, Prometheus Research said. HTSQL is a software

The results showed that administering fluticasone with OptiNose’s device is effective in the treatment of refractory CRS, with significant and clinically relevant improvements compared with placebo in both

Let-7 was the first miRNA that was demonstrated to function as a tumor suppressor via its ability to regulate oncogene expression, Mirna Therapeutics said. Mirna Therapeutics said that

iGPS claimed that the new service iGPS bios provides a level of pallet hygiene and security that cannot be achieved with pallets made of wood or other organic